Hipotensión permisiva en trauma / Permissive hypotension in trauma

Resumen Introducción: El shock hemorrágico es una de las causas más comunes de muerte en pacientes con trauma debido a que pone en marcha un círculo vicioso de mecanismos que incluyen hipotermia, acidosis y coagulopatía. Para mitigar estos efectos, se han propuesto estrategias de control de daños, incluido el aporte controlado de líquidos con hipotensión permisiva contemplando metas en la presión arterial sistólica para mantener una adecuada perfusión de los tejidos. Objetivo: Conocer información actualizada acerca del manejo de la hipotensión permisiva en pacientes con trauma. Metodología: Se buscó información en las bases de datos Web-of-Science y Scopus de los últimos cinco años. El resultado arrojó un total de 118 artículos de los cuales se tomaron 30, según los criterios de inclusión y exclusión. Resultados: Todos los artículos consideran el uso de la hipotensión permisiva como una buena opción para el manejo de los pacientes con trauma e hipotensión, sin embargo, difieren en qué momento es adecuado utilizarlo y en qué condiciones se debe realizar. Conclusiones: Si bien la hipotensión permisiva se ha convertido en uno de los pilares fundamentales en el manejo prehospitalario del paciente con trauma, se requieren estudios investigativos en humanos para soportar cuándo y cómo debe utilizarse.

Abstract Introduction: Hemorrhagic shock is one of the most common causes of death in trauma patients, because it sets in motion a vicious cycle of mechanisms, including hypothermia, acidosis, and coagulopathy. To mitigate these effects, damage control strategies have been proposed, including the controlled intake of fluids with permissive hypotension, contemplating goals in systolic blood pressure, and thus, maintaining adequate tissue perfusion. Objective: The present research aimed to review the literature in search of updated information about the management of permissive hypotension in patients with trauma. Methodology: Information was searched in the Web-of-Science and Scopus databases in the last five years. The result yielded a total of 118 articles, of which 30 were taken according to the inclusion and exclusion criteria. Results: All the articles consider the use of permissive hypotension as a good option for the management of patients with trauma and hypotension, however, they differ when it is appropriate to use it and under what conditions it should be performed. Conclusions: Although permissive hypotension has become one of the fundamental pillars in the prehospital management of the patient with trauma, research studies in humans are required to support when and how it should be used.

Atualização na reanimação volêmica no paciente traumatizado / Update on volemic resuscitation in trauma patient

Introdução: O choque hipovolêmico é o principal tipo de choque no trauma. Seu manejo é fundamental visto que é uma das principais causas de mortes evitáveis. Objetivos: Definir conceitos relacionados à reanimação no choque hipovolêmico, como coagulopatia precoce no trauma, controle de danos, hipotensão permissiva, uso de cristaloides e hemoderivados, ácido tranexâmico e protocolo de transfusão maciça. Metodologia: Busca na base de dados bibliográfica Medline/Pubmed e LILACS no período de maio de 2018, incluindo artigos de revisão, revisões sistemáticas e guidelines cuja publicação seja em inglês ou português e remeta os últimos 5 anos. Os descritores foram "permissive hypotension" ou "damage control resuscitation". "hypovolemic shock". Os artigos foram selecionados com busca direta, considerando relevância do tema à proposta e revista com fator de impacto mensurado. Resultados: Foram apresentados 342 resultados da busca de dados, nos quais 15 artigos foram selecionados. Na conduta do choque hipovolêmico, responsável por 30 a 40% das mortes no período de 24 horas após o trauma, adota-se a hipotensão permissiva e preconiza-se o controle de danos. Conclusões: O entendimento da coagulopatia no trauma, do uso limitado de cristaloides, da reanimação balanceada, da hipotensão permissiva, da correta indicação do ácido tranexâmico e da aplicação do protocolo de transfusão maciça é fundamental na reanimação volêmica do paciente traumatizado.

Introduction: The hypovolemic shock is the main type of shock in trauma patients. Its management is fundamental given that hemorrhagic shock is one of the main causes of death that can be avoided. Aims: To define concepts related to resuscitation in hypovolemic shock, such as early coagulopathy in trauma, damage control, permissive hypotension, use of crystalloids and blood derivatives, tranexamic acid and massive transfusion protocol. Methods: Search in the bibliographic database Medline/Pubmed and LILACS in the period of May 2018, including review articles, systematic reviews and guidelines published in either English or Portuguese in the last 5 years. The descriptors were "permissive hypotension" or "damage control resuscitation". Of the 342 results, 15 articles were selected with direct search, considering relevance of the theme to the proposal and reviewed with measured impact factor. Results: From 342 results in database, 10 articles have been selected. The management of hypovolemic shock, responsible for 30-40% of deaths within 24 hours of trauma, permissive hypotension and damage control have been recommended. Conclusion: The understanding of coagulopathy in trauma, of limited use of crystalloids, of balanced resuscitation, of permissive hypotension, of the correct indication of tranexamic acid and of the application of the protocol of massive transfusion is essential in the resuscitation of the trauma patient.

Doing Less is Better: Challenges in Complex Polytrauma Management - Case Report

Damage control resuscitation, characterized by hemostatic resuscitation with blood products, rapid arrest of bleeding and when possible, permissive hypotension with restricted fluid load form a structured approach in managing a polytrauma patient. When complicated with traumatic rhabdomyolysis however, permissive hypotension strategy may cause more harm resulting in subsequent ischaemic-reperfusion injury and acute kidney injury. We present a case involving a 20-year-old man who was rolled over by a lorry and sustained an open unstable pelvic fracture with vascular injury and left lower limb ischaemia. Permissive hypotension strategy was pursued for 4 hours prior to bleeding control in OT. This was followed by protracted surgery of 6 hours. Coagulopathy, acute kidney injury and rhabdomyolysis ensued in the post-operative period and patient succumbed to his injury on Day 3 post-trauma. Challenges and pitfalls in managing a complex polytrauma patient and recent evidences on damage control resuscitation is discussed.

Hidroxietilalmidón (Hextend®) en solución electrolítica balanceada en el choque hipovolémico hemorrágico / Use of hetastarch in a balanced electrolyte solution - Hextend®- in the resuscitation of the patient in hypovolemic hemmorrhagic shock: review of the international literature

Hextend® is a preparation of hetilstarch in a balanced electrolyte solution that contains 143 mEq/L of sodium, 124mEq/L of chloride, 5 mEq/L of calcium 3 mEq/L of potassium 0.9 mEq/L of magnesium, 0.99 g/L of glucose and 24 mEq/L of lactate. It has a volume of distribution similar to blood volume which enables it to stay in the intravascular compartment until it is renally cleared or absorbed by the reticuloendothelial system. It shows a bimodal pattern of clearance with a half life during the first 8 hrs of its infusion of 4.2 hrs and during the 7 days following of 38.2 hrs. Hextend® is currently one of the preferred resuscitation solutions in the hypovolemic patient showing a better profile of effects over hemostasis and acid base status and conferring a better survival over similar patients resuscitated with crystalloids or other synthetic colloids. Hextend® provides an adequate fluid that is effective in the resuscitation of the trauma patient in hypovolemic hemorrhagic shock and promises to become the fluid of choice in the routine management of these patients. There is a need of more randomized prospective studies in the field of trauma using Hextend ® and its combination with the inflammatory cascade modifiers such as ethyl pyruvate among others.

Hextend® es una combinación de hetilalmidón balanceada en una solución de electrolitos que contiene 143 mEq/L de sodio, 124 mEq/L de cloro, 5 mEq/L de calcio, 3 mEq/L de potasio, 0,9 mEq/L de magnesio, 0,99 g/L de glucosa y 24 mEq/L de lactato. Posee un volumen de distribución equivalente al volumen sanguíneo manteniéndose en el compartimento vascular hasta ser excretado vía renal o absorbido por el sistema retículo-endotelial. Estas características le confieren un patrón farmacocinético bimodal con una vida media de 4,2 horas durante las primeras 8 hrs de infusión y de 38,2 h durante los primeros 7 días. Hextend® es actualmente una de las soluciones de reanimación con mejor perfil de efectos sobre la hemostasia y el equilibrio ácido base del paciente en choque hipovolémico y confiere un aumento de la sobrevida, comparado con controles resucitados con cristaloides u otros coloides sintéticos. Esta combinación de hetilalmidón en una solución amortiguadora electrolítica posee mínimos efectos sobre la función hemostática y plaquetaria por lo que actualmente es preferido frente a soluciones cristaloides y otros coloides utilizados en el pasado en la reanimación de pacientes politraumatizados en estado de choque hipovolémico hemorrágico. A su vez, promete transformarse en el fluido de elección en el manejo rutinario de estos pacientes. En relación al uso de este producto es imperativo realizar un mayor número de estudios prospectivos randomizados. La literatura internacional augura un esplendoroso futuro al uso de Hextend®, como también a su posible combinación con modificadores de la cascada inflamatoria, entre otros con el etil piruvato.